Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization

mAbs

Volumn 2, Issue 3, 2010, Pages 275-284

  Martín Folgar, Raquel ^a   Lorenzo, Gema ^a   Boshra, Hani ^a   Iglesias, Javier ^a   Mateos, Francisco ^a   Borrego, Belén ^a   Brun, Alejandro ^a  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

Author keywords

Competitive ELISA; Nucleoprotein; RVF; RVFV lineages

Indexed keywords

MONOCLONAL ANTIBODY; NUCLEOCAPSID PROTEIN;

ANTIBODY DETECTION; ARTICLE; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; NONHUMAN; RIFT VALLEY FEVER BUNYAVIRUS; VIRUS STRAIN; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NUCLEOCAPSID PROTEINS; PLASMIDS; RECOMBINANT PROTEINS; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SEQUENCE ALIGNMENT;

EID: 77953664480     PISSN: 19420862     EISSN: None     Source Type: Journal    
DOI: 10.4161/mabs.2.3.11676     Document Type: Article

References (28)

1. Gerdes GH. Rift Valley fever. Rev Sci Tech 2004; 23:613-623
2. Moutailler S, Krida G, Schaffner F, Vazeille M, Failloux AB. Potential vectors of Rift Valley fever virus in the Mediterranean region. Vector Borne Zoonotic Dis 2008; 8:749-753
3. López-Vélez R, Molina R. Climate change in Spain and risk of infectious and parasitic diseases transmitted by arthropods and rodents. Rev Esp Salud Pública 2005; 79:177-190 (Pubitemid 40571160)
4. Coetzer JA, Ishak KG. Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus I. Macroscopic and microscopic pathology. Onderstepoort J Vet Res 1982; 49:103-108
5. Coetzer JA, Ishak KG, Calvert RC. Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus II. Ultrastructural findings. Onderstepoort J Vet Res 1982; 49:109-122
6. Arthur RR, el-Sharkawy MS, Cope SE, Botros BA, Oun S, Morrill JC, et al. Recurrence of Rift Valley fever in Egypt. Lancet 1993; 342:1149-1150
7. Al-Hazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, El-Bushra A, et al. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 2003; 36:245-252 (Pubitemid 36169657)
8. Bird BH, Ksiazek TG, Nichol ST, Maclachlan NJ. Rift Valley fever virus. J Am Vet Med Assoc 2009; 234:883-893
9. Evans A, Gakuya F, Paweska JT, Rostal M, Akoolo L, Van Vuren PJ, et al. Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife. Epidemiol Infect 2008; 136:1261-1269
10. Paweska JT, van Vuren PJ, Kemp A, Buss P, Bengis RG, Gakuya F, et al. Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo. Vet Microbiol 2008; 127:21-28 (Pubitemid 350267044)
11. Paweska JT, Mortimer E, Leman PA, Swanepoel R. An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in humans, domestic and wild ruminants. J Virol Methods 2005; 127:10-18 (Pubitemid 40704632)
12. Flick R, Bouloy M. Rift Valley fever virus. Curr Mol Med 2005; 5:827-834
13. Le May N, Gauliard N, Billecocq A, Bouloy M. The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization. J Virol 2005; 79:11974-11980 (Pubitemid 41279314)
14. Koser ML, McGettigan JP, Tan GS, Smith ME, Koprowski H, Dietzschold B, Schnell MJ. Rabies virus nucleoprotein as a carrier for foreign antigens. Proc Natl Acad Sci USA 2004; 101:9405-9410 (Pubitemid 38812887)
15. Mebatsion T, Koolen MJ, de Vaan LT, de Haas N, Braber M, Romer-Oberdorfer A, et al. Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J Virol 2002; 76:10138-10146
16. Gould EA, Higgs S. Impact of climate change and other factors on emerging arbovirus diseases. Trans R Soc Trop Med Hyg 2009; 103:109-121
17. Paweska JT, Jansen van Vuren P, Swanepoel R. Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans. J Virol Methods 2007; 146:119-124 (Pubitemid 350026626)
18. Jansen van Vuren P, Potgieter AC, Paweska JT, van Dijk AA. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. J Virol Methods 2007; 140:106-114 (Pubitemid 46185598)
19. Meegan JM, Digoutte JP, Peters CJ, Shope RE. Monoclonal antibodies to identify Zinga virus as Rift Valley Fever virus. Lancet 1983; 1:641.
20. Besselaar TG, Blackburn NK, Meenehan GM. Antigenic analysis of Rift Valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains. Res Virol 1991; 142:469-474
21. Besselaar TG, Blackburn NK. Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies. Arch Virol 1991; 121:111-124
22. Blackburn NK, Besselaar TG. A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies. J Virol Methods 1991; 33:367-374
23. Besselaar TG, Blackburn NK. The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins. Arch Virol 1992; 125:239-250
24. Besselaar TG, Blackburn NK. The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity. Res Virol 1994; 145:13-19
25. Zaki A, Coudrier D, Yousef AI, Fakeeh M, Bouloy M, Billecocq A. Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera. J Virol Methods 2006; 131:34-40. (Pubitemid 41772558)
26. Caplen H, Peters CJ, Bishop DH. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 1985; 66:2271-2277 (Pubitemid 15250309)
27. Lorenzo G, Martin-Folgar R, Rodriguez F, Brun A. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep. Vaccine 2008; 26:5255-5262
28. Galfre G, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 1981; 73:3-46.